International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
The aim of this special issue is to showcase the remarkable progress made in the field of external beam radiation therapy for the treatment of solid tumors. We will delve into the latest achievements and innovations that have significantly improved the efficacy and safety of this critical oncological treatment modality while providing insight into the promising future directions it is poised to take. Over the past several decades, external beam radiation therapy has evolved into a cornerstone in the management of solid tumors. It has played a pivotal role in enhancing the quality of life and survival rates of cancer patients across the globe. One of the key achievements in modern radiotherapy is the development of advanced imaging and targeting techniques. These innovations have enabled the delivery of precise radiation doses to tumor sites while sparing healthy tissues, thus minimizing side effects and improving patients' overall well-being. The integration of cutting-edge technologies such as image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT) has improved clinical outcomes in practice. Furthermore, there have been substantial strides in treatment planning and optimization algorithms. These advancements have empowered radiation oncologists to tailor treatment regimens with unprecedented precision, leading to higher tumor control rates and reduced toxicity. The emergence of artificial intelligence and machine learning in treatment planning will also be explored, highlighting their potential to further enhance treatment outcomes. In addition to focusing on achievements, this special issue will provide insights into the future of external beam radiation therapy. We will discuss emerging trends, such as the incorporation of immunotherapy and personalized medicine into radiation treatment protocols. Furthermore, we will explore the potential role of radiomics and radiogenomics in refining treatment strategies and predicting treatment response. In summary, this special issue aims to reveal the remarkable achievements in external beam radiation therapy for solid tumors while shedding light on the promising horizons that await us. By providing a comprehensive overview of the current state of the field and its future directions, we hope to inspire collaboration, innovation, and a continued commitment to improving cancer care for patients worldwide.
Immune microenvironment and treatment response of dMMR gastric cancer: Heterogeneity and implications for immunotherapy
Unveiling mitochondrial DNA copy number alterations: Insights into progression from cervical intraepithelial neoplasia to cervical cancer
Cerebral infarctions caused by pulmonary vein metastasis from gastric cancer: A case report
NDC80 kinetochore complex component is a potential molecular target of adenoid cystic carcinoma
[Retracted] MicroRNA‑429 inhibits gastric cancer migration and invasion through the downregulation of specificity protein 1
Endostar combined with docetaxel or cisplatin in the management of malignant ascites through hyperthermic intraperitoneal chemotherapy: A retrospective cohort study
Three‑dimensional culture of tumor cells (Review)
Cytotoxic, apoptotic and genotoxic effects of thymoquinone‑oxime derivative on gastric cancer cells: An in vitro study
Tumor microenvironment in gastric cancer immune tolerance and its therapeutic relevance in immunomodulation (Review)
Phosphorylated‑EGFR and MMP7 upregulation in gastric cancer: Association with metastasis and poor prognosis
Study on the expression level of folate receptor γ in thyroid cancer and its association with clinicopathological characteristics
Prognostic value of glioma‑associated oncogene homolog 1 and SET domain‑containing protein 2 immunohistochemical scores in locally advanced cervical cancer
[Retracted] Clinical significance of bromodomain‑containing protein 7 and its association with tumor progression in prostate cancer
Circular RNA hsa_circ_0006168: A potential biomarker for the diagnosis and prognosis of prostate cancer
Meta‑analysis of the clinical efficacy of anti‑PD‑1/L1 + paclitaxel/albumin‑paclitaxel + platinum vs. paclitaxel/albumin‑paclitaxel + platinum in the treatment of patients with advanced non‑small cell lung cancer
Progress in perioperative immunotherapy for lung cancer and analysis of therapy (Review)
Advances in targeting vasculogenic mimicry in malignant tumors using monomeric compounds from Traditional Chinese Medicine (Review)
Preoperative lymphocyte‑albumin‑monocyte index as an inflammation‑ and nutrition‑based predictor of overall survival in triple‑negative breast cancer: A retrospective cohort study
Combination of extracellular vesicles and organoids as a prospective model for cancer research (Review)
Recurrent microsatellite instability‑high thymic carcinoma showing complete response to immune checkpoint inhibitor: A case report